Zdrowie i gospodarka · 23/09/2014

FDA Releases Draft Report on Standardizing Risk Evaluation and Mitigation Strategies

The Food and Drug Administration (FDA) has released a draft report outlining its plan to standardize risk evaluation and mitigation strategies (REMS) in an effort to reduce the burden on healthcare professionals and patients. The report is part of the reauthorization of the Prescription Drug User Fee Act (PDUFA) and invites public comment.